Immunoregulatory networks in human Chagas disease
暂无分享,去创建一个
[1] K. Gollob,et al. Low levels of vasoactive intestinal peptide are associated with Chagas disease cardiomyopathy. , 2013, Human immunology.
[2] I. Mendoza,et al. ECG Manifestations of the Biggest Outbreak of Chagas Disease due to Oral Infection in Latin-America , 2013, Arquivos brasileiros de cardiologia.
[3] O. Campetella,et al. Differential Distribution of Genes Encoding the Virulence Factor Trans-Sialidase along Trypanosoma cruzi Discrete Typing Units , 2013, PloS one.
[4] M. C. Nunes,et al. High interleukin 17 expression is correlated with better cardiac function in human Chagas disease. , 2013, The Journal of infectious diseases.
[5] S. Adad,et al. An imbalance between substance P and vasoactive intestinal polypeptide might contribute to the immunopathology of megaesophagus after Trypanosoma cruzi infection. , 2013, Human pathology.
[6] R. Fujiwara,et al. Regenerative process evaluation of neuronal subclasses in chagasic patients with megacolon. , 2013, Human immunology.
[7] A. Fontenot,et al. Highly conserved CDR3 region in circulating CD4+Vβ5+ T cells may be associated with cytotoxic activity in Chagas disease , 2012, Clinical and experimental immunology.
[8] A. Teixeira-Carvalho,et al. Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity. , 2012, Immunobiology.
[9] E. C. Oliveira,et al. Preponderance of inhibitory versus excitatory intramuscular nerve fibres in human chagasic megacolon , 2012, International Journal of Colorectal Disease.
[10] E. C. Oliveira,et al. Selective survival of calretinin- and vasoactive-intestinal-peptide-containing nerve elements in human chagasic submucosa and mucosa , 2012, Cell and Tissue Research.
[11] F. A. Martins,et al. IFN-γ Plays a Unique Role in Protection against Low Virulent Trypanosoma cruzi Strain , 2012, PLoS neglected tropical diseases.
[12] M. Llewellyn,et al. The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications. , 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[13] S. Montgomery,et al. Trypanosoma cruzi and Chagas' Disease in the United States , 2011, Clinical Microbiology Reviews.
[14] F. H. Santello,et al. Prolactin: does it exert an up-modulation of the immune response in Trypanosoma cruzi-infected rats? , 2011, Veterinary parasitology.
[15] D. Pena,et al. Selection of TcII Trypanosoma cruzi population following macrophage infection. , 2011, The Journal of infectious diseases.
[16] S. D. Silva-Barbosa,et al. Immunoneuroendocrine alterations in patients with progressive forms of chronic Chagas disease , 2011, Journal of Neuroimmunology.
[17] J. Scharfstein,et al. Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells , 2010, Clinical and experimental immunology.
[18] S. D. Pena,et al. Differential tissue tropism of Trypanosoma cruzi strains: an in vitro study. , 2010, Memorias do Instituto Oswaldo Cruz.
[19] M. C. Nunes,et al. Trypanosoma cruzi-Induced Activation of Functionally Distinct αβ and γδ CD4− CD8− T Cells in Individuals with Polar Forms of Chagas' Disease , 2010, Infection and Immunity.
[20] Y. Iwakura,et al. IL-17 Is Necessary for Host Protection against Acute-Phase Trypanosoma cruzi Infection , 2010, The Journal of Immunology.
[21] J. Coura,et al. Chagas disease: a new worldwide challenge , 2010, Nature.
[22] K. Maemura,et al. Lineage Analysis of Circulating Trypanosoma cruzi Parasites and Their Association with Clinical Forms of Chagas Disease in Bolivia , 2010, PLoS neglected tropical diseases.
[23] J. Silva,et al. IL-17 Produced during Trypanosoma cruzi Infection Plays a Central Role in Regulating Parasite-Induced Myocarditis , 2010, PLoS neglected tropical diseases.
[24] A. Romanha,et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. , 2009, Memorias do Instituto Oswaldo Cruz.
[25] A. Krettli. The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives. , 2009, Memorias do Instituto Oswaldo Cruz.
[26] C. R. Machado,et al. Probing Population Dynamics of Trypanosoma cruzi during Progression of the Chronic Phase in Chagasic Patients , 2009, Journal of Clinical Microbiology.
[27] G. Franco,et al. The MHC Gene Region of Murine Hosts Influences the Differential Tissue Tropism of Infecting Trypanosoma cruzi Strains , 2009, PloS one.
[28] K. Gollob,et al. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. , 2009, The Journal of infectious diseases.
[29] A. Teixeira-Carvalho,et al. Strategy to Assess the Overall Cytokine Profile of Circulating Leukocytes and its Association with Distinct Clinical Forms of Human Chagas Disease , 2008, Scandinavian journal of immunology.
[30] R. Corrêa-Oliveira,et al. Substance P and NK1 receptor expression in the enteric nervous system is related to the development of chagasic megacolon. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[31] J. Scharfstein,et al. Bradykinin B2 Receptors of Dendritic Cells, Acting as Sensors of Kinins Proteolytically Released by Trypanosoma cruzi, Are Critical for the Development of Protective Type-1 Responses , 2007, PLoS pathogens.
[32] A. Ribeiro,et al. An update on the management of Chagas cardiomyopathy , 2007, Expert review of anti-infective therapy.
[33] S. Williams-Blangero,et al. Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease. , 2007, Frontiers in bioscience : a journal and virtual library.
[34] E. C. Oliveira,et al. Neurochemical Coding of the Enteric Nervous System in Chagasic Patients with Megacolon , 2007, Digestive Diseases and Sciences.
[35] C. Carneiro,et al. Trypanosoma cruzi high infectivity in vitro is related to cardiac lesions during long-term infection in Beagle dogs. , 2007, Memorias do Instituto Oswaldo Cruz.
[36] E. Segura,et al. Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina , 2006, Current opinion in infectious diseases.
[37] Á. Moncayo,et al. An update on Chagas disease (human American trypanosomiasis) , 2006, Annals of tropical medicine and parasitology.
[38] Alessandro Sette,et al. CD8+ T-Cell Responses to Trypanosoma cruzi Are Highly Focused on Strain-Variant trans-Sialidase Epitopes , 2006, PLoS pathogens.
[39] U. Renner,et al. Hypothalamus–pituitary–adrenal axis during Trypanosoma cruzi acute infection in mice , 2006, Journal of Neuroimmunology.
[40] I. Watanabe,et al. Trypanosoma cruzi: preliminary investigation of NADH-positive and somatostatin-immunoreactive neurons in the myenteric plexus of the mouse colon during the infection. , 2005, Experimental parasitology.
[41] M. M. Teixeira,et al. Predominance of lineage I among Trypanosoma cruzi isolates from Venezuelan patients with different clinical profiles of acute Chagas’ disease , 2004, Tropical medicine & international health : TM & IH.
[42] M. O. Rocha,et al. Monocytes from Patients with Indeterminate and Cardiac Forms of Chagas' Disease Display Distinct Phenotypic and Functional Characteristics Associated with Morbidity , 2004, Infection and Immunity.
[43] D. Pozo,et al. The many faces of VIP in neuroimmunology: a cytokine rather a neuropeptide? , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] A. Ribeiro,et al. Elevated Concentrations of CCL2 and Tumor Necrosis Factor—α in Chagasic Cardiomyopathy , 2004 .
[45] R. Tarleton,et al. Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. , 2004, The Journal of infectious diseases.
[46] S. D. Pena,et al. Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease. , 2004, Memórias do Instituto Oswaldo Cruz.
[47] A. Teixeira-Carvalho,et al. Phenotypic Features of Peripheral Blood Leucocytes During Early Stages of Human Infection with Trypanosoma cruzi , 2003, Scandinavian journal of immunology.
[48] C. Machado,et al. Trypanosoma cruzi: mixture of two populations can modify virulence and tissue tropism in rat. , 2003, Experimental parasitology.
[49] R. Corrêa-Oliveira,et al. Evidence that Development of Severe Cardiomyopathy in Human Chagas' Disease Is Due to a Th1-Specific Immune Response , 2003, Infection and Immunity.
[50] E. Douzery,et al. Evidence for genetic exchange and hybridization in Trypanosoma cruzi based on nucleotide sequences and molecular karyotype. , 2003, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[51] R. Gazzinelli,et al. Chemokines, inflammation and Trypanosoma cruzi infection. , 2002, Trends in parasitology.
[52] A. Todeschini,et al. Costimulation of Host T Lymphocytes by a Trypanosomal trans-Sialidase: Involvement of CD43 Signaling1 , 2002, The Journal of Immunology.
[53] F. Noireau,et al. Integrate study of a Bolivian population infected by Trypanosoma cruzi, the agent of Chagas disease. , 2002, Memorias do Instituto Oswaldo Cruz.
[54] A. Frasch,et al. A Trypanosoma cruzi Small Surface Molecule Provides the First Immunological Evidence that Chagas' Disease Is Due to a Single Parasite Lineage , 2002, The Journal of experimental medicine.
[55] S. Brisse,et al. Characterisation of large and small subunit rRNA and mini-exon genes further supports the distinction of six Trypanosoma cruzi lineages. , 2001, International journal for parasitology.
[56] C. Mady,et al. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. , 2001, Journal of autoimmunity.
[57] S. Brisse,et al. Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers. , 2000, Molecular and biochemical parasitology.
[58] S. D. Pena,et al. Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. , 2000, The American journal of pathology.
[59] Brener,et al. Self and Nonself Stimulatory Molecules Induce Preferential Expansion of CD5+ B Cells or Activated T Cells of Chagasic Patients, Respectively , 2000, Scandinavian journal of immunology.
[60] B. Zingales,et al. Epidemiology, biochemistry and evolution of Trypanosoma cruzi lineages based on ribosomal RNA sequences. , 1999, Memorias do Instituto Oswaldo Cruz.
[61] M. Tibayrenc,et al. Trypanosoma cruzi: compared vectorial transmissibility of three major clonal genotypes by Triatoma infestans. , 1998, Experimental parasitology.
[62] M. Tibayrenc,et al. Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. , 1998, Experimental parasitology.
[63] M. Tibayrenc,et al. Compared vectorial transmissibility of pure and mixed clonal genotypes of Trypanosoma cruzi in Triatoma infestans , 1998, Parasitology Research.
[64] S. D. Pena,et al. Genetic Variability of Trypanosoma cruzi:Implications for the Pathogenesis of Chagas Disease. , 1998, Parasitology today.
[65] F. Pileggi,et al. Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. , 1997, The American journal of tropical medicine and hygiene.
[66] M. Tibayrenc,et al. Impact of clonal evolution on the biological diversity of Trypanosoma cruzi , 1997, Parasitology.
[67] M. Lazarus,et al. An investigation of polymorphism in the interleukin-10 gene promoter. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[68] R. Coffman,et al. Cytokine mRNA Profile of Peripheral Blood Mononuclear Cells Isolated from Individuals with Trypanosoma cruzi Chronic Infection , 1997, Scandinavian journal of immunology.
[69] J. Aliberti,et al. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages , 1995, Infection and immunity.
[70] E. Jones,et al. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. , 1993, The American journal of tropical medicine and hygiene.
[71] M. Miles,et al. DO RADICALLY DISSIMILAR TRYPANOSOMA CRUZI STRAINS (ZYMODEMES) CAUSE VENEZUELAN AND BRAZILIAN FORMS OF CHAGAS' DISEASE? , 1981, The Lancet.
[72] D. Taub. Neuroendocrine interactions in the immune system. , 2008, Cellular immunology.
[73] M. Soares,et al. Characterization of Trypanosoma cruzi isolated from humans, vectors, and animal reservoirs following an outbreak of acute human Chagas disease in Santa Catarina State, Brazil. , 2008, Diagnostic microbiology and infectious disease.
[74] R. Glaser,et al. Stress hormones and immune function. , 2008, Cellular immunology.
[75] A. Rassi,et al. Specific treatment for Trypanosoma cruzi: lack of efficacy of allopurinol in the human chronic phase of Chagas disease. , 2007, The American journal of tropical medicine and hygiene.
[76] G. Vargas-Alarcón,et al. MHC class I and class II genes in Mexican patients with Chagas disease. , 2004, Human immunology.
[77] A. Ribeiro,et al. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[78] S. Brisse,et al. Identification of six Trypanosoma cruzi phylogenetic lineages by random amplified polymorphic DNA and multilocus enzyme electrophoresis. , 2000, International journal for parasitology.
[79] R. Coffman,et al. IFN-gamma in human Chagas' disease: protection or pathology? , 1998, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[80] M. Tibayrenc. Genetic epidemiology of parasitic protozoa and other infectious agents: the need for an integrated approach. , 1998, International journal for parasitology.
[81] M. Tibayrenc. Kinetoplastid Biology and Disease Genetic Subdivisions within Trypanosoma Cruzi (discrete Typing Units) and Their Relevance for Molecular Epidemiology and Experimental Evolution , 2022 .